EPM News Update
Particle Sciences has received a Notice of Allowance on a method of manufacturing and delivery of aerosolised drug carrying particles. According to Mark Mitchnick, MD, Chief Executive Officer, “This latest patent is a nice addition. It stems from work we did a number of years back and adds to the increasing pool of proprietary and public domain approaches Particle Sciences can offer its clients. Through in-house invention and strategic acquisition, Particle Sciences will continue to build a technology portfolio aimed at giving our clients a tangible competitive advantage.”
Particle Sciences is a leader in particulate-based drug delivery, with a focus on commercially ready advanced drug delivery technologies. This particular technology can use generally recognised as safe (GRAS) excipients and offers a very efficient and scalable method for companies looking for a pulmonary delivery system.
Particle Sciences, +1 610 861 4701, info@particlesciences.com, www.particlesciences.com.